A cellular therapy for ocular degeneration

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01)

Patent

CA 2613889

Compositions and methods applicable to cell-based or regenerative therapy for ophthalmic diseases and disorders comprising mesenchymal stem cells, particularly those characterized by the expression of at least one of the following surface markers: CD29, CD44, CD105 or CD166, and the lack of expression of at least one of CD14, CD34 or CD45.

L'invention concerne des compositions et des procédés servant à la thérapie cellulaire ou régénératrice pour des maladies ou troubles ophtalmiques et comprenant des cellules souches mésenchymateuses, notamment celles caractérisées par l'expression d'au moins un des marqueurs de surface suivants : CD29, CD44, CD105 ou CD166, et par l'absence d'expression d'au moins un marqueur parmi CD14, CD34 ou CD45.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A cellular therapy for ocular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A cellular therapy for ocular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A cellular therapy for ocular degeneration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1606771

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.